BIOMAT Database Logo BIOMAT Database Logo

Design, synthesis, and biological activity of a peptide mimic of vasopressin. 1988

W M Bryan, and J C Hempel, and W F Huffman, and G R Marshall, and M L Moore, and J Silvestri, and F L Stassen, and J S Stefankiewicz, and L Sulat, and R L Webb
Department of Peptide Chemistry, Smith Kline and French Laboratories, Swedeland, Pennsylvania 19479.

Our molecular modeling studies suggested that the conformational effects of the "cystine-line" residue Pmp1-Cys6 on the cyclohexapeptide ring of the vasopressin antagonist [Pmp1,D-Phe2,Val4]AVP might be mimicked by substitution of D-aminoadipic acid at position 6 and cyclization of its side-chain carboxyl to the alpha-amine of residue 2. The peptide was prepared with DL-aminoadipic acid, and following cyclization, the two diastereomeric peptides were separated and purified by preparative high-performance liquid chromatography. The structure of each was confirmed by amino acid analysis and fast atom bombardment mass spectrometry. The chirality of the aminoadipic acid residue of each peptide was determined by chiral gas chromatography. The circular dichroism spectrum of each peptide was run and compared with the appropriate agonist and antagonist peptide standards. These peptides demonstrated in vitro poor V2-receptor affinity and an inability to inhibit or stimulate vasopressin-induced adenylate cyclase formation, suggesting that they lack one or more key features of the agonist/antagonist pharmacophore.

UI MeSH Term Description Entries
D007679 Kidney Medulla The internal portion of the kidney, consisting of striated conical masses, the renal pyramids, whose bases are adjacent to the cortex and whose apices form prominent papillae projecting into the lumen of the minor calyces. Kidney Papilla,Kidney Medullas,Kidney Papillas,Medulla, Kidney,Medullas, Kidney,Papilla, Kidney,Papillas, Kidney
D008236 Lypressin The porcine antidiuretic hormone (VASOPRESSINS). It is a cyclic nonapeptide that differs from ARG-VASOPRESSIN by one amino acid, containing a LYSINE at residue 8 instead of an ARGININE. Lys-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE. Lysine Vasopressin,Vasopressin, Lysine,8-Lysine Vasopressin,Diapid,Lys-Vasopressin,Lysyl Vasopressin,Postacton,8 Lysine Vasopressin,Lys Vasopressin,Vasopressin, 8-Lysine,Vasopressin, Lysyl
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011945 Receptors, Angiotensin Cell surface proteins that bind ANGIOTENSINS and trigger intracellular changes influencing the behavior of cells. Angiotensin Receptor,Angiotensin Receptors,Angiotensin II Receptor,Angiotensin III Receptor,Receptor, Angiotensin II,Receptor, Angiotensin III,Receptor, Angiotensin
D000067956 Adenylyl Cyclase Inhibitors Compounds that bind to and inhibit the action of ADENYLYL CYCLASES. Adenylate Cyclase Inhibitors,Cyclase Inhibitors, Adenylate,Cyclase Inhibitors, Adenylyl,Inhibitors, Adenylate Cyclase,Inhibitors, Adenylyl Cyclase
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

W M Bryan, and J C Hempel, and W F Huffman, and G R Marshall, and M L Moore, and J Silvestri, and F L Stassen, and J S Stefankiewicz, and L Sulat, and R L Webb
Synthesis and biological activity of a biotinylated vasopressin analog.
January 1990, Peptides,
W M Bryan, and J C Hempel, and W F Huffman, and G R Marshall, and M L Moore, and J Silvestri, and F L Stassen, and J S Stefankiewicz, and L Sulat, and R L Webb
Design, synthesis and biological activity of cell-penetrating peptide-modified octreotide analogs.
February 2010, Journal of peptide science : an official publication of the European Peptide Society,
W M Bryan, and J C Hempel, and W F Huffman, and G R Marshall, and M L Moore, and J Silvestri, and F L Stassen, and J S Stefankiewicz, and L Sulat, and R L Webb
Fluorescent pseudo-peptide linear vasopressin antagonists: design, synthesis, and applications.
April 1999, Journal of medicinal chemistry,
W M Bryan, and J C Hempel, and W F Huffman, and G R Marshall, and M L Moore, and J Silvestri, and F L Stassen, and J S Stefankiewicz, and L Sulat, and R L Webb
Design, Synthesis, and Biological Activity of Isosyringolin A.
May 2016, Organic letters,
W M Bryan, and J C Hempel, and W F Huffman, and G R Marshall, and M L Moore, and J Silvestri, and F L Stassen, and J S Stefankiewicz, and L Sulat, and R L Webb
Design, synthesis, and biological activity of novel dicoumarol glucagon-like peptide 1 conjugates.
December 2013, Journal of medicinal chemistry,
W M Bryan, and J C Hempel, and W F Huffman, and G R Marshall, and M L Moore, and J Silvestri, and F L Stassen, and J S Stefankiewicz, and L Sulat, and R L Webb
Design and Application of Peptide-Mimic Phosphonium Salt Catalysts in Asymmetric Synthesis.
November 2023, Angewandte Chemie (International ed. in English),
W M Bryan, and J C Hempel, and W F Huffman, and G R Marshall, and M L Moore, and J Silvestri, and F L Stassen, and J S Stefankiewicz, and L Sulat, and R L Webb
Peptide-lisinopril conjugates: design, synthesis and biological activities.
January 2009, Advances in experimental medicine and biology,
W M Bryan, and J C Hempel, and W F Huffman, and G R Marshall, and M L Moore, and J Silvestri, and F L Stassen, and J S Stefankiewicz, and L Sulat, and R L Webb
Design, synthesis and biological activity of protaxols.
July 1993, Nature,
W M Bryan, and J C Hempel, and W F Huffman, and G R Marshall, and M L Moore, and J Silvestri, and F L Stassen, and J S Stefankiewicz, and L Sulat, and R L Webb
Rational design of potent mimic peptide derived from monoclonal antibody: antibody mimic design.
May 2005, Immunology letters,
W M Bryan, and J C Hempel, and W F Huffman, and G R Marshall, and M L Moore, and J Silvestri, and F L Stassen, and J S Stefankiewicz, and L Sulat, and R L Webb
Design, synthesis, and characterization of a model peptide having potent calcitonin-like biological activity: implications for calcitonin structure/activity.
April 1985, Biochemistry,
Copied contents to your clipboard!